| 1a. | Re-elect Christopher Causey - Non-Executive Director | Oppose |
| 1b. | Re-elect Richard Giltner - Non-Executive Director | Oppose |
| 1c. | Re-elect Ray Kurzweil - Non-Executive Director | Oppose |
| 1d. | Re-elect Jan Malcolm - Non-Executive Director | For |
| 1e. | Re-elect Linda Maxwell - Non-Executive Director | For |
| 1f. | Re-elect Nilda Mesa - Non-Executive Director | For |
| 1g. | Re-elect Judy D. Olian - Non-Executive Director | Oppose |
| 1h. | Re-elect Christopher Patusky - Senior Independent Director | Oppose |
| 1i. | Re-elect Martine Rothblatt - Chair & Chief Executive | Oppose |
| 1j. | Re-elect Louis Sullivan - Non-Executive Director | Oppose |
| 1k. | Re-elect Tommy Thompson - Non-Executive Director | Oppose |
| 1l. | Elect Kevin Tracey - Non-Executive Director | For |
| 2. | Advisory Vote on Executive Compensation | Oppose |
| 3. | Approval of the United Therapeutics Corporation 2026 Stock Incentive Plan | Oppose |
| 4. | Ratification of the appointment of Ernst & Young LLP as our independent registered public accounting firm for 2026 | Oppose |
